Abstract

BackgroundThe present study carried out a meta‐analysis to investigate whether the interleukin‐1 receptor antagonist (IL‐1RN) VNTR polymorphism and three IL‐10 single‐nucleotide polymorphisms (SNPs) rs1800896, rs3021097, and rs1800872 are associated with psoriasis risk.MethodsWanfang, China National Knowledge Infrastructure, Medline, and PubMed databases were searched for potential studies published until 2 November 2017. Forest plots were generated.ResultsThirteen case–control studies were included in the review. The results of meta‐analyses revealed no association of the IL‐1RN*2 allele with psoriasis in the overall populations (odds ratio [OR] = 1.16, 95% confidence intervals [CI]: 0.89–1.50, p = 0.279), Asians (OR = 1.27, 95% CI: 0.73–2.23, p = 0.403), and Caucasians (OR = 1.04, 95% CI: 0.88–1.23, p = 0.669). Under the allelic model, there was no statistically significant association of psoriasis with the IL‐10 SNPs rs1800896 (G allele vs. A allele: OR = 1.03, 95% CI: 0.90–1.18, p = 0.639), rs3021097 (C allele vs. T allele: OR = 1.17, 95% CI: 0.88–1.56, p = 0.288), and rs1800872 (C allele vs. A allele: OR = 1.01, 95% CI: 0.81–1.25, p = 0.951). No publication bias was found by Egger's test and Begg's funnel plots.ConclusionCurrent published studies fail to support an association of the IL‐1RN VNTR polymorphism and IL‐10 SNPs rs1800896, rs3021097, and rs1800872 with psoriasis risk.

Highlights

  • Psoriasis is a common inflammatory disease of the skin affecting 2% of the population (Boehncke & Schon, 2015)

  • The present study carried out a meta‐analysis to investigate whether the interleukin‐1 receptor antagonist (IL‐1RN) variable number tandem repeat (VNTR) polymorphism and three IL‐10 single‐nucleotide polymorphisms (SNPs) rs1800896, rs3021097, and rs1800872 are associated with psoriasis risk

  • Since Interleukin‐1 receptor antagonist (IL‐1Ra) is involved in the inflammatory responses within psoriatic plaques, dermatologists have carried out genetic studies to assess the relationship of the IL‐1RN VNTR polymorphism with psoriasis risk

Read more

Summary

| INTRODUCTION

Psoriasis is a common inflammatory disease of the skin affecting 2% of the population (Boehncke & Schon, 2015). Since IL‐1Ra is involved in the inflammatory responses within psoriatic plaques, dermatologists have carried out genetic studies to assess the relationship of the IL‐1RN VNTR polymorphism with psoriasis risk. Three single‐nucleotide polymorphisms (SNPs) at ‐592A/C (rs1800872), ‐819C/T (rs3021097), and ‐1082A/G (rs1800896) in the IL‐10 promoter region have recently been evaluated in a number of genetic association studies regarding their relationship with psoriasis susceptibility, but the findings of these studies are contradictory. Both IL‐1Ra and IL‐10 are important anti‐inflammatory cytokines in psoriasis pathogenesis.

82 Not available
56.8 PCR‐RFLP
| Ethical compliance
| RESULTS
Findings
| DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call